Suchergebnisse - "JAK inhibitor"

PubPharm (172)

1

Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color

enthalten in: JAAD case reports | 2024

von Wambier, C.

2

Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF

enthalten in: Journal of clinical immunology | 2024

von Koh, J. | Kim, D. | Son, S. | +10

3

Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib

enthalten in: Journal of clinical immunology | 2024

von Dotta, L. | Todaro, F. | Baronio, M. | +13

4

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

enthalten in: EJHaem | 2024

von Oh, S. | Verstovsek, S. | Gupta, V. | +15

5

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults : pooled results from 2 phase 3 studies

enthalten in: The Journal of dermatological treatment | 2024

von Simpson, E. | Bissonnette, R. | Chiesa Fuxench, Z. | +4

6

JAK inhibitor treatment for inborn errors of JAK/STAT signaling : An ESID/EBMT-IEWP retrospective study

enthalten in: The Journal of allergy and clinical immunology | 2024

von Fischer, M. | Olbrich, P. | Hadjadj, J. | +54

7

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease

enthalten in: Frontiers in immunology | 2024

von De Togni, E. | Cole, O. | Abboud, R.

8

A safety evaluation of ruxolitinib for the treatment of polycythemia vera

enthalten in: Expert opinion on drug safety | 2024

von Boldrini, V. | Vannucchi, A. | Guglielmelli, P.

9

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

in: eJHaem | 2024

von Stephen T. Oh | Srdan Verstovsek | Vikas Gupta | +15

10

Response to Papp et al's "Long-term safety and disease control with ruxolitinib cream in atopic dermatitis : Results from two phase 3 studies"

enthalten in: Journal of the American Academy of Dermatology | 2024

von Isaq, N. | Link, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]